Adiponectin exerts anti-tumor activity by suppressing the secretion of pro-inflammatory cytokines, e.g., IL-6 and TNF-α, lessening the chronic inflammation related to obesity or the anti-inflammatory effect [49]. Here, ADIPOQ is linked to neoplasm.